by Hal B. Jenson, M.D.
Chief, Pediatric Infectious Diseases
University of Texas Health Science Center
San Antonio, TX
by Charles T. Leach, M.D.
Associate Professor of Pediatrics
University of Texas Health Science Center
San Antonio, TX

What is roseola?

Roseola, also known as “roseola infantum” or “exanthem subitum,” is a viral infection
that is characterized primarily by a high fever and a rash.


What causes roseola?

Human herpesvirus type 6 (HHV6) and, sometimes, human herpesvirus type 7 (HHV7)
cause roseola. Both are members of the herpesvirus family of viruses.


Who gets roseola?

Almost all children are infected during early childhood with HHV6 and HHV7, but
only about one-third of children develop signs of roseola. The peak age for developing
roseola is 6 to 15 months of age. More than 95% of cases occur in children younger
than 3 years of age.


How do HHV6 and HHV7 cause disease?

HHV6 and HHV7 are transmitted from person-to-person by direct contact or by contaminated
secretions of the nose and the mouth. These viruses are spread through the blood
throughout the body, which causes the rash.


What are the common findings?

The majority of children with roseola develop a characteristic illness with a very
high fever (from 100F to 103F) for approximately three days, which is followed by
the onset of a rash the day that the fever resolves. In contrast to what is usually
expected with such a high fever, most children, during the fever, behave quite normally
and continue with their usual play activities. Some infants may become irritable
and have a decreased appetite. In classic cases, the rash typically appears within
24 hours after the fever resolves and then fades over one to three days; however,
only approximately 25% of infected children may actually develop the rash.


How is roseola diagnosed?

Roseola is diagnosed primarily on the characteristically high fever followed by
the development of the rash once the fever resolves. Unfortunately, this makes it
very difficult to diagnose roseola during the course of the fever because, typically,
there are no other symptoms.

There is a blood test that is available, but, usually, this is not used for diagnosis
because either the illness has resolved completely after a few days, or the diagnosis
can be made by the physician with some certainty because of the characteristic high
fever followed by the rash.


How is roseola treated?

There is no specific treatment for roseola. Antibiotics are not helpful because
a virus causes roseola. Viruses cannot be treated with antibiotics. The disease
is usually mild with complete recovery. Fever should be treated with acetaminophen
or ibuprofen.


What are the complications?

The major complication of roseola in children is the development of febrile seizures.
During the time of the high fever, especially early in the infection, children may
have seizures that are caused by the very high fever. Febrile seizures occur in
2% to 3% of all children, and usually are a problem between 6 months and 3 to 4
years of age. Many cases of febrile seizures that occur only once in a child are
probably due to roseola.


How can roseola be prevented?

A vaccine for roseola is not available. There is very little information on how
to prevent roseola; however, outbreaks are uncommon. The spread of roseola can be
prevented by minimizing exposure to children who have symptoms of the disease, and
by good handwashing after exposure to the disease.


What research is being done?

Research is being conducted on the transmission of human herpesvirus 6 and to characterize
how the virus causes roseola.


About the Authors

Hal Jenson, M.D.

Dr. Jenson graduated from George Washington University School of Medicine in Washington,

He also completed a residency in pediatrics at the Rainbow Babies and Children’s
Hospital of Case Western Reserve University in Cleveland, Ohio, and a fellowship
in pediatric infectious diseases and epidemiology at Yale University School of Medicine.

Dr. Jenson has an active research program on the biology of Epstein-Barr virus and
other human and non-human primate herpes viruses.

He is active in the general pediatric and infectious diseases teaching and clinical
activities of his Department and Division, is a co-editor of Nelson Textbook of
Pediatrics and of Pediatric Infectious Diseases: Principles and Practice, and authors
the book Pocket Guide to Vaccination and Prophylaxis.

Charles T. Leach, M.D.

Dr. Leach received his medical degree at the University of Utah School of Medicine
and completed his pediatrics residency as well as a fellowship in pediatric infectious
diseases at UCLA.

He is currently Associate Professor and Director of Research in the Department of
Pediatrics at the University of Texas Health Science Center at San Antonio.

Dr. Leach conducts scientific research in the areas of herpes virus infections,
pediatric AIDS, and infectious diseases among residents of the Texas-Mexico border.

Copyright 2012 Hal B. Jenson, M.D., and Charles T. Leach, M.D., All Rights Reserved